Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

被引：0
|
作者：
Makoto Sudo
Tan Min Chin
Seiichi Mori
Ngan B. Doan
Jonathan W. Said
Makoto Akashi
H. Phillip Koeffler
机构：
[1] National University of Singapore,Cancer Science Institute
[2] National University Hospital,Department of Hematology and Oncology
[3] The Cancer Institute,Department of Cancer Genomics
[4] Japanese Foundation for Cancer Research,Department of Pathology and Laboratory Medicine
[5] University of California,Research Center for Radiation Emergency
[6] National Institute of Radiological Sciences,Division of Hematology and Oncology
[7] Cedars-Sinai Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Non-small cell lung cancer (NSCLC); Tyrosine kinase inhibitor (TKI); EGFR; 17-DMAG; Belinostat; Combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1325 / 1334
页数：9
相关论文
共 50 条
  • [1] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [2] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
    Sin, Thomas K.
    Wang, Fengfeng
    Meng, Fei
    Wong, S. C. Cesar
    Cho, William C. S.
    Siu, Parco M.
    Chan, Lawrence W. C.
    Yung, Benjamin Y. M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [3] Atractyloside inhibits gefitinib-resistant non-small-cell lung cancer cell proliferation
    Yao, Wanxin
    Liu, Chen
    Zhang, Ningyin
    Zhang, Yanmei
    Qian, Yong
    [J]. ONCOLOGY LETTERS, 2024, 28 (04)
  • [4] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [5] Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
    Heasley, Lynn E.
    Marek, Lindsay
    Fritzsche, Alexa
    Helton, Wallace R.
    Nemenoff, Raphael A.
    McDermott, Lee A.
    Helfrich, Barbara
    Bunn, Paul A.
    [J]. FASEB JOURNAL, 2008, 22
  • [6] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    [J]. JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [7] Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
    Li, Xia
    Fan, Xing-Xing
    Jiang, Ze-Bo
    Loo, Wings T. Y.
    Yao, Xiao-Jun
    Leung, Elaine Lai-Han
    Chow, Louis W. C.
    Liu, Liang
    [J]. PHARMACOLOGICAL RESEARCH, 2017, 115 : 45 - 55
  • [8] Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
    Chen, Mu-Tong
    Li, Bai-Zhi
    Zhang, En-Pu
    Zheng, Qing
    [J]. MEDICINE, 2023, 102 (40) : E35086
  • [9] The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
    Mohiuddin, Md
    Kasahara, Kazuo
    [J]. CANCER GENOMICS & PROTEOMICS, 2021, 18 (05) : 661 - 673
  • [10] Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    Koyama, Nobuyuki
    Uchida, Yoshitaka
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 5083 - 5089
12345